MOLECULAR TEMPLATES INC's ticker is MTEM and the CUSIP is 608550109. A total of 46 filers reported holding MOLECULAR TEMPLATES INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 850 | +163.2% | 0.00% | – |
| Q1 2023 | $0 | – | 323 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 323 | -14.1% | 0.00% | – |
| Q3 2022 | $0 | – | 376 | +19.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 315 | -86.1% | 0.00% | – |
| Q1 2022 | $8,000 | -75.0% | 2,272 | -72.5% | 0.00% | – |
| Q4 2021 | $32,000 | -8.6% | 8,259 | +59.3% | 0.00% | – |
| Q3 2021 | $35,000 | +66.7% | 5,186 | +97.7% | 0.00% | – |
| Q2 2021 | $21,000 | +162.5% | 2,623 | +335.7% | 0.00% | – |
| Q1 2021 | $8,000 | +700.0% | 602 | +447.3% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 110 | +120.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 50 | -50.5% | 0.00% | – |
| Q1 2020 | $1,000 | -94.7% | 101 | -92.6% | 0.00% | – |
| Q4 2019 | $19,000 | +1800.0% | 1,364 | +555.8% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 208 | +73.3% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 120 | +20.0% | 0.00% | – |
| Q1 2018 | $1,000 | -96.2% | 100 | -96.2% | 0.00% | – |
| Q4 2017 | $26,000 | +44.4% | 2,613 | +3.9% | 0.00% | – |
| Q3 2017 | $18,000 | – | 2,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,137,991 | $8,381,000 | 6.85% |
| ACUTA CAPITAL PARTNERS, LLC | 322,500 | $1,264,000 | 0.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,021,317 | $4,004,000 | 0.46% |
| BVF INC/IL | 3,129,599 | $12,268,000 | 0.44% |
| Bellevue Group AG | 10,878,003 | $42,642,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 1,374,047 | $5,386,000 | 0.42% |
| Endurant Capital Management LP | 268,375 | $1,052,000 | 0.25% |
| Abingworth LLP | 200,000 | $780,000 | 0.19% |
| Parkman Healthcare Partners LLC | 147,728 | $579,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 145,329 | $570,000 | 0.07% |